Citius Pharmaceuticals Inc
For the period ended Jun 30, 2024. Filed Aug 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 12, 2024
CTXR$0.53-3.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| 1.1 | At the Market Offering Agreement, dated as of August 12, 2024, between Citius Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC. |
| 4.1 | Form of Investor Warrant issued on April 30, 2024 (incorporated by reference to Exhibit 4.1 to the Form 8-K filed on April 30, 2024). |
| 5.1 | Opinion of Wyrick Robbins Yates & Ponton LLP. |
| 10.1 | Form of Securities Purchase Agreement, dated as of April 25, 2024, by and among Citius Pharmaceuticals, Inc. and the investors signatory thereto (incorporated by reference to Exhibit 10.1 to the Form 8-K filed on April 30, 2024). |
| 23.1 | Consent of Wyrick Robbins Yates & Ponton LLP (included in Exhibit 5.1). |
| 31.1 | Certification of the Principal Executive Officer pursuant to Exchange Act Rule 13a-14(a).* |
| 31.2 | Certification of the Principal Financial Officer pursuant to Exchange Act Rule 13a-14(a).* |
| 32.1 | Certification of the Principal Executive and Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.* |
| EX-101.INS | Inline XBRL Instance Document* |
| EX-101.SCH | Inline XBRL Taxonomy Extension Schema Document* |
| EX-101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document* |
| EX-101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document* |
| EX-101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document* |
| EX-101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document* |
| EX-104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
| * | Filed herewith. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.